LTRN · NASDAQ
Lantern Pharma (LTRN) Stock Price & Fundamentals
Lantern Pharma (LTRN) closed at $1,120.27 on Oct 9, 2026, down 1.51% from the previous close of $1,137.42.
Share price, past year
1Y +12.33%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $1,120.27 |
| Sep 30, 2026 | $1,137.94 |
| Aug 31, 2026 | $1,138.66 |
| Jul 31, 2026 | $1,035.70 |
| Jun 30, 2026 | $1,037.73 |
| May 29, 2026 | $1,076.66 |
| Apr 30, 2026 | $1,048.20 |
| Mar 31, 2026 | $1,004.29 |
| Feb 27, 2026 | $976.28 |
| Jan 30, 2026 | $979.71 |
| Dec 31, 2025 | $968.09 |
| Nov 28, 2025 | $980.37 |
| Oct 31, 2025 | $972.34 |
Key statistics
- Market cap
- $14.29B
- EPS (TTM)
- −$1.62
- Net income (TTM)
- −$18.65M
- Shares outstanding
- 12.8M
- 52-week range
- $940.37 – $1,186.21
Lantern Pharma's market cap is $14.29B, based on a share price of $1,120.27 and 12.8M shares outstanding as of Jun 30, 2026.
Financials
Lantern Pharma's SEC filings don't report revenue in the standard form Laurel reads, so its revenue history isn't shown yet.
Lantern Pharma reported a net loss of $17.12M in fiscal 2025.
Company profile
- Name
- Lantern Pharma Inc.
- Ticker
- LTRN
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Pharmaceutical Preparations
- Headquarters
- 1920 Mckinney Avenue, 7th Floor, Dallas, TX 75201
- Incorporated in
- TX
- Fiscal year ends
- December
- SEC CIK
- 0001763950
Recent SEC filings
- Oct 1, 2026
- Sep 30, 2026
- Sep 24, 2026
- Sep 23, 2026
- Aug 14, 2026
- Aug 14, 2026
- Aug 3, 2026
- Jun 2, 2026
Frequently asked questions
What is Lantern Pharma's stock price?
Lantern Pharma (LTRN) closed at $1,120.27 on Oct 9, 2026, down 1.51% from the previous close of $1,137.42.
What is Lantern Pharma's market cap?
Lantern Pharma's market cap is $14.29B, based on a share price of $1,120.27 and 12.8M shares outstanding as of Jun 30, 2026.
Does Lantern Pharma pay a dividend?
Lantern Pharma's recent filings report no dividends declared over the last four quarters.
Sources and methodology
Fundamentals come from Lantern Pharma Inc.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures